Brown C B, Nicholls A J, Edward N, Cuthbertson B, Yap P L, McClelland D B
Proc Eur Dial Transplant Assoc. 1983;20:271-9.
Eleven renal transplant patients with CMV infection have been treated by passive immunisation, one with high-titre anti-CMV plasma and 10 with fractionated hyperimmune anti-CMV immunoglobulin. All were pyrexial for at least seven days before treatment with typical clinical and laboratory features of CMV infection. Seven of the 11 patients treated showed a striking and sustained response within 24-48 hours of therapy, with lysis of fever, resolution of pneumonitis, a rise in white cell count and improvement in renal function and liver function tests.
11名患有巨细胞病毒（CMV）感染的肾移植患者接受了被动免疫治疗，1名患者接受了高滴度抗CMV血浆治疗，10名患者接受了分级超免疫抗CMV免疫球蛋白治疗。所有患者在接受治疗前至少发热7天，具有CMV感染的典型临床和实验室特征。接受治疗的11名患者中有7名在治疗后24至48小时内表现出显著且持续的反应，包括退热、肺炎消退、白细胞计数升高以及肾功能和肝功能检查结果改善。
